Biphasic effect of exogenous nitric oxide on proliferation and differentiation in skin derived keratinocytes but not fibroblasts.

Nitric oxide (NO) is known to exert cytotoxic and cytostatic effects in various cells and tissues. Although NO formation in human skin has been convincingly demonstrated, little is known about the NO-mediated effects in skin physiology and pathology. Here, we investigate the influence of NO on proliferation, differentiation, and apoptosis of primary cultures of normal human keratinocytes and fibroblasts. Four different NO donors at concentrations ranging from 0.01 to 5 mM were added every 12 h or 24 h to primary cultures of human keratinocytes and fibroblasts, and cells cultured for up to 3 d in the presence of these compounds. Cultures were examined for necrosis or apoptosis using trypan blue exclusion and in situ nick-translation. Cultures were also screened for the expression of the proliferation marker Ki67 and for an increase in cell numbers using neutral red staining. In addition, keratinocytes were stained for cytokeratin 6 expression to assess differentiation. We find that both keratinocytes and fibroblasts are highly resistant towards necrosis- or apoptosis-inducing effects of NO. In both cell types NO modulates cell growth, albeit in a cell-type specific pattern: cytostasis becomes significant in fibroblasts at concentrations of > or = 0.25 mM of the NO donor. In keratinocytes a biphasic effect is found with increased proliferation at low concentrations ranging from 0.01 to 0.25 mM and cytostasis at concentrations of > or = 0.5 mM. Conversely, expression of cytokeratin 6 is decreased at the lower NO donor concentrations and increased at higher concentrations as an indication of induction of differentiation at higher NO concentrations. Collectively, our results demonstrate that NO modulates proliferation and differentiation in human skin cells, a finding that will help to explain the pathophysiology of human skin diseases. Moreover, these findings suggest that NO generation in human skin diseases is not directly associated with local cell destruction, in contrast to findings in several other human diseases.

[1]  S. Gansauge,et al.  Exogenous, but not endogenous, nitric oxide increases proliferation rates in senescent human fibroblasts , 1997, FEBS letters.

[2]  K. Kröncke,et al.  Nitric oxide mediates intracytoplasmic and intranuclear zinc release , 1997, FEBS letters.

[3]  R. Sobel,et al.  Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. , 1997, Journal of immunology.

[4]  M-F Du,et al.  Promotion of proliferation of murine BALB/c3T3 fibroblasts mediated by nitric oxide at lower concentrations , 1997, Biochemistry and molecular biology international.

[5]  C. Suschek,et al.  A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes , 1996, The Journal of experimental medicine.

[6]  R. Schwartz Models of T cell anergy: is there a common molecular mechanism? , 1996, The Journal of experimental medicine.

[7]  M. Mcdaniel,et al.  Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human islets. , 1996, The American journal of physiology.

[8]  I. Arany,et al.  Regulation of inducible nitric oxide synthase mRNA levels by differentiation and cytokines in human keratinocytes. , 1996, Biochemical and biophysical research communications.

[9]  M Laurent,et al.  Kinetic modelling of the nitric oxide gradient generated in vitro by adherent cells expressing inducible nitric oxide synthase. , 1996, The Biochemical journal.

[10]  R. Moll,et al.  Epithelial markers and differentiation in adnexal neoplasms of the skin: an immunohistochemical study including individual cytokeratins , 1995, Journal of cutaneous pathology.

[11]  Keiichiro Suzuki,et al.  Apoptotic Cell Death Triggered by Nitric Oxide in Pancreatic β-Cells , 1995, Diabetes.

[12]  K. Kröncke,et al.  Inducible nitric oxide synthase and its product nitric oxide, a small molecule with complex biological activities. , 1995, Biological chemistry Hoppe-Seyler.

[13]  A. Sommer,et al.  Nitric oxide generation during cellular metabolization of the diabetogenic N-methyl-N-nitroso-urea streptozotozin contributes to islet cell DNA damage. , 1995, Biological chemistry Hoppe-Seyler.

[14]  M. Nakane,et al.  Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. , 1994, Hypertension.

[15]  A. Jetten,et al.  Control of growth regulatory and differentiation-specific genes in human epidermal keratinocytes by interferon gamma. Antagonism by retinoic acid and transforming growth factor beta 1. , 1994, The Journal of biological chemistry.

[16]  H. Kolb,et al.  Pancreatic islet cells are highly susceptible towards the cytotoxic effects of chemically generated nitric oxide. , 1993, Biochimica et biophysica acta.

[17]  A. Nussler,et al.  Inflammation, immunoregulation, and inducible nitric oxide synthase , 1993, Journal of leukocyte biology.

[18]  J. Albina,et al.  Nitric oxide-mediated apoptosis in murine peritoneal macrophages. , 1993, Journal of immunology.

[19]  B. Czarnetzki,et al.  Patterns of cell death: the significance of apoptosis for dermatology , 1993, Experimental dermatology.

[20]  E. Fuchs,et al.  Evidence for posttranscriptional regulation of the keratins expressed during hyperproliferation and malignant transformation in human epidermis , 1986, The Journal of cell biology.

[21]  H Stein,et al.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. , 1984, Journal of immunology.

[22]  J. Mcguire,et al.  Two keratins MW 50,000 and 56,000 are synthesized by psoriatic epidermis , 1984, The British journal of dermatology.

[23]  Elaine Fuchs,et al.  Changes in keratin gene expression during terminal differentiation of the keratinocyte , 1980, Cell.

[24]  V. Kolb-Bachofen,et al.  Nitric oxide in human skin: current status and future prospects. , 1998, The Journal of investigative dermatology.

[25]  A. Butler,et al.  The physiological role of nitric oxide , 1993 .

[26]  H. Kolb,et al.  Nitric oxide: a pathogenetic factor in autoimmunity. , 1992, Immunology today.